← Research status explorer
Enhance / Reproductive & pigmentation
Melanotan II
Current research status
Human Research
Early/historical human research
Preclinical
Human Research
Overview
Melanotan II is a non-selective melanocortin-receptor agonist studied in early human pharmacology research for tanning and libido effects in the 1990s–2000s. It was never advanced through a conventional Phase 1–3 program to approval; more selective successor compounds — afamelanotide and bremelanotide — were developed and approved instead for specific, narrower indications.
Sources
Last reviewed: September 2026
